Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sortase B is a membrane-anchored enzyme (~246 amino acids) present in numerous Gram-positive bacterial species, including *Staphylococcus*, *Bacillus*, *Listeria*, and *Clostridium*. It catalyzes the transpeptidation reaction required to covalently link surface proteins—particularly those with the NPQTN sorting motif—to the peptidoglycan layer near the cell membrane. Its major function is to facilitate the acquisition of heme-iron by anchoring iron-scavenging proteins, essential for bacterial survival and pathogenicity during infection. It is structurally characterized by an eight-stranded β-barrel core and a distinctive β6/β7 loop that dictates substrate specificity. Disruption of Sortase B impairs iron uptake and can attenuate the virulence of pathogenic bacteria, making it a promising target for anti-infective therapies. No clinically approved drugs target Sortase B as of now, but inhibition has shown potential in preclinical studies.
Inhibition of Sortase B blocks anchoring of iron-scavenging proteins, hindering bacterial iron acquisition and reducing virulence
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sortase B (SrtB).